EP
INSM icon

Essential Partners’s Insmed INSM Stock Holding History

Essential Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Buy
119
+109
+1,090% +$13.2K 0.01% 1103
2026
Q1 		$1.64K Sell
10
-58
-85% -$8.92K ﹤0.01% 2081
2025
Q4 		$11.8K Buy
68
+56
+467% +$10.2K ﹤0.01% 1104
2025
Q3 		$1.73K Buy
12
+10
+500% +$1.23K ﹤0.01% 1839
2025
Q2 		$201 Buy
+2
New +$153 ﹤0.01% 1940

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Essential Partners's INSM Position: Q2 2026 in Review

Essential Partners increased its Insmed (INSM) stake by 1,090% in Q2 2026, buying an estimated $13.2K and bringing the position to 119 shares worth $12.7K. The position accounts for 0.01% of the portfolio, ranked #1103.

Essential Partners first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Essential Partners held 119 shares of Insmed worth $12.7K as of Q2 2026.
  • Essential Partners bought 109 Insmed shares in Q2 2026, an estimated $13.2K.
  • Insmed made up 0.01% of Essential Partners's portfolio in Q2 2026, its #1103 holding.
  • Essential Partners first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.